Estimated cancer risks attributable to radiation dose in ureteral stenting procedures
Autor(a) principal: | |
---|---|
Data de Publicação: | 2008 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://doi.org/10.25758/set.44 |
Resumo: | Introduction: Double-J ureteral stenting is a frequent interventional urological procedure that implicates the use of x-ray fluoroscopy, with considerable exposure times, incident in an anatomic region with several organs. This fact raises doubts about the patient risks attributed to radiation dose. The purpose of this study was to clarify these doubts in estimating the cancer risk inherent to the patient's effective dose. Method: We studied specific data of 146 patients submitted to ureteral stenting procedures in the Urologic Department of Hospital Santa Maria. Effective doses were determined with a computational Monte Carlo-based program. Cancer risks were estimated with probability coefficients considering the linear non-threshold dose-effect relation (LNT) of the low doses of radiation. Results: A patient submitted to a ureteral stent insertion followed by a removal procedure, develops an increased cancer risk of 0,012%. This means that 1 in 8330 patients develops radiation-induced cancer. Also, a patient submitted to a ureteral stent insertion followed by 1 substitution, and a removal procedure is submitted to a mean effective dose of 4,47 mSv. This value is similar to the effective dose of an abdominal TC. Conclusion: When we compare the radiation risks with the clinical benefit, of “saving” renal function, we can conclude that benefits are greatly more important than risks. Furthermore, we verify that, although low, there is always some risk attributed to radiation dose. Thus, dose optimization and clinical justification should always be considered in these procedures. |
id |
RCAP_eeaeec7fb4558f91aae963c5b5f37e7e |
---|---|
oai_identifier_str |
oai:journals.ipl.pt:article/766 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Estimated cancer risks attributable to radiation dose in ureteral stenting proceduresEstimativa do risco de carcinogénese associado à radiação X no cateterismo ureteral “duplo J”Cateterismo ureteralRadiação XDoseRiscoCarcinogéneseUreteral stentingX-rayDoseRiskCancerIntroduction: Double-J ureteral stenting is a frequent interventional urological procedure that implicates the use of x-ray fluoroscopy, with considerable exposure times, incident in an anatomic region with several organs. This fact raises doubts about the patient risks attributed to radiation dose. The purpose of this study was to clarify these doubts in estimating the cancer risk inherent to the patient's effective dose. Method: We studied specific data of 146 patients submitted to ureteral stenting procedures in the Urologic Department of Hospital Santa Maria. Effective doses were determined with a computational Monte Carlo-based program. Cancer risks were estimated with probability coefficients considering the linear non-threshold dose-effect relation (LNT) of the low doses of radiation. Results: A patient submitted to a ureteral stent insertion followed by a removal procedure, develops an increased cancer risk of 0,012%. This means that 1 in 8330 patients develops radiation-induced cancer. Also, a patient submitted to a ureteral stent insertion followed by 1 substitution, and a removal procedure is submitted to a mean effective dose of 4,47 mSv. This value is similar to the effective dose of an abdominal TC. Conclusion: When we compare the radiation risks with the clinical benefit, of “saving” renal function, we can conclude that benefits are greatly more important than risks. Furthermore, we verify that, although low, there is always some risk attributed to radiation dose. Thus, dose optimization and clinical justification should always be considered in these procedures.Introdução: Porque o cateterismo ureteral “duplo J” implica a exposição do doente a radiação X, com tempos de exposição consideráveis, incidentes numa região anatómica constituída por diversos órgãos, existem dúvidas em relação aos riscos associados à dose de radiação acumulada pelos doentes. O objectivo deste trabalho centrou-se em clarificar estas dúvidas através da estimação quantitativa do risco de carcinogénese associado à dose de radiação. Método: Foram estudados dados relativos a 146 doentes submetidos a procedimentos de cateterismo ureteral “duplo J” no Serviço de Urologia do Hospital de Santa Maria (HSM). As doses eficazes foram determinadas através de métodos Monte Carlo. O risco de carcinogénese foi estimado com base na relação linear dose/efeito, sem limiar de dose, por coeficientes de probabilidade. Resultados: Como resultados mais relevantes, estimou-se que 1 colocação seguida de 1 extracção do cateter “duplo J” proporciona ao doente um risco acrescido de carcinogénese de 0,012%, ou seja, cerca de 1 doente em 8330 desenvolve cancro radio-‑induzido. Estima-se também, por exemplo, que um doente submetido a 1 colocação, 1 substituição e 1 extracção é, em média, submetido a uma dose eficaz de 4,47mSv, valor de dose semelhante ao proporcionado por uma TC abdominal. Conclusão: Quando comparamos os riscos associados à radiação com o benefício clínico de “poupar” a função renal, concluímos que os benefícios são inestimavelmente mais importantes que os riscos. De qualquer forma, verificamos que existe sempre, ainda que relativamente baixo, algum risco associado aos níveis de dose. Assim, os princípios da Justificação e da Optimização deverão ser sempre equacionados neste tipo de procedimentos.Escola Superior de Tecnologia da Saúde de Lisboa (Instituto Politécnico de Lisboa)2008-04-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.25758/set.44https://doi.org/10.25758/set.44Saúde e Tecnologia; No. 01 (2008): Maio 2008; 30-35Saúde & Tecnologia; N.º 01 (2008): Maio 2008; 30-351646-9704reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://journals.ipl.pt/stecnologia/article/view/766https://journals.ipl.pt/stecnologia/article/view/766/656Direitos de Autor (c) 2023 Saúde & Tecnologiainfo:eu-repo/semantics/openAccessRibeiro, TiagoMartins, CláudiaRocha, Marta2023-05-26T08:30:13Zoai:journals.ipl.pt:article/766Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:56:04.260404Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Estimated cancer risks attributable to radiation dose in ureteral stenting procedures Estimativa do risco de carcinogénese associado à radiação X no cateterismo ureteral “duplo J” |
title |
Estimated cancer risks attributable to radiation dose in ureteral stenting procedures |
spellingShingle |
Estimated cancer risks attributable to radiation dose in ureteral stenting procedures Ribeiro, Tiago Cateterismo ureteral Radiação X Dose Risco Carcinogénese Ureteral stenting X-ray Dose Risk Cancer |
title_short |
Estimated cancer risks attributable to radiation dose in ureteral stenting procedures |
title_full |
Estimated cancer risks attributable to radiation dose in ureteral stenting procedures |
title_fullStr |
Estimated cancer risks attributable to radiation dose in ureteral stenting procedures |
title_full_unstemmed |
Estimated cancer risks attributable to radiation dose in ureteral stenting procedures |
title_sort |
Estimated cancer risks attributable to radiation dose in ureteral stenting procedures |
author |
Ribeiro, Tiago |
author_facet |
Ribeiro, Tiago Martins, Cláudia Rocha, Marta |
author_role |
author |
author2 |
Martins, Cláudia Rocha, Marta |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Ribeiro, Tiago Martins, Cláudia Rocha, Marta |
dc.subject.por.fl_str_mv |
Cateterismo ureteral Radiação X Dose Risco Carcinogénese Ureteral stenting X-ray Dose Risk Cancer |
topic |
Cateterismo ureteral Radiação X Dose Risco Carcinogénese Ureteral stenting X-ray Dose Risk Cancer |
description |
Introduction: Double-J ureteral stenting is a frequent interventional urological procedure that implicates the use of x-ray fluoroscopy, with considerable exposure times, incident in an anatomic region with several organs. This fact raises doubts about the patient risks attributed to radiation dose. The purpose of this study was to clarify these doubts in estimating the cancer risk inherent to the patient's effective dose. Method: We studied specific data of 146 patients submitted to ureteral stenting procedures in the Urologic Department of Hospital Santa Maria. Effective doses were determined with a computational Monte Carlo-based program. Cancer risks were estimated with probability coefficients considering the linear non-threshold dose-effect relation (LNT) of the low doses of radiation. Results: A patient submitted to a ureteral stent insertion followed by a removal procedure, develops an increased cancer risk of 0,012%. This means that 1 in 8330 patients develops radiation-induced cancer. Also, a patient submitted to a ureteral stent insertion followed by 1 substitution, and a removal procedure is submitted to a mean effective dose of 4,47 mSv. This value is similar to the effective dose of an abdominal TC. Conclusion: When we compare the radiation risks with the clinical benefit, of “saving” renal function, we can conclude that benefits are greatly more important than risks. Furthermore, we verify that, although low, there is always some risk attributed to radiation dose. Thus, dose optimization and clinical justification should always be considered in these procedures. |
publishDate |
2008 |
dc.date.none.fl_str_mv |
2008-04-30 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.25758/set.44 https://doi.org/10.25758/set.44 |
url |
https://doi.org/10.25758/set.44 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://journals.ipl.pt/stecnologia/article/view/766 https://journals.ipl.pt/stecnologia/article/view/766/656 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2023 Saúde & Tecnologia info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2023 Saúde & Tecnologia |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Escola Superior de Tecnologia da Saúde de Lisboa (Instituto Politécnico de Lisboa) |
publisher.none.fl_str_mv |
Escola Superior de Tecnologia da Saúde de Lisboa (Instituto Politécnico de Lisboa) |
dc.source.none.fl_str_mv |
Saúde e Tecnologia; No. 01 (2008): Maio 2008; 30-35 Saúde & Tecnologia; N.º 01 (2008): Maio 2008; 30-35 1646-9704 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799131636182286336 |